Global Stabilizers Used in Antibody Drugs and Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Stabilizers Used in Antibody Drugs and Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Antibodies are Y-shaped proteins produced by the body as part of the normal immune response to foreign molecules. Molecules from invading organisms - such as viruses, bacteria and other harmful organisms - are called antigens and prompt the body's B cells to produce billions of antibodies. Each antibody has two antigen-binding sites (one on each arm of Y) that can neutralize these invaders. Antibody drugs are based on key principles of biology, mimicking the body's and immune system's natural defenses and pathways. Scientists study how antibodies work to replicate and optimize for specific disease targets. Antibody drugs can now be made in the lab and given to people who need them for specific medical purposes.

Market Overview:

The latest research study on the global Stabilizers Used in Antibody Drugs and Vaccines market finds that the global Stabilizers Used in Antibody Drugs and Vaccines market reached a value of USD 390.33 million in 2022. It’s expected that the market will achieve USD 324.73 million by 2028, exhibiting a CAGR of -3.02% during the forecast period.

Drivers

Vaccines are known to lose potency over time, especially when stored in suboptimal conditions such as ambient or warm temperatures. Since vaccines are often used in developing countries where it is difficult to maintain optimal storage conditions, there is a great need to develop methods in which the ability of vaccine compositions to elicit a protective immune response in a subject does not diminish over time. Great improvements in stability and shelf life have been achieved for various vaccine compositions. There are mainly two strategies used to improve stability. First, low temperature storage (eg -10 to -70 degrees Celsius) has been used, but maintaining such temperatures is often not feasible, especially in developing countries. The second method is to freeze-dry (freeze-dry) and reconstitute it into a liquid form before use. However, lyophilized vaccine compositions also lose efficacy over time. Furthermore, in both strategies, further improvements have been achieved by adding one or more stabilizers to the vaccine composition. In developing countries where it is difficult to maintain optimal storage conditions, the availability and development of stabilizers has made vaccine rollout more accessible. This drives the development of the industry.
With the improvement of economic level, people's living standards improve, and per capita disposable income also increases. In general, higher per capita income allows people to buy more goods and services, increase access to education, and increase access to health care. On the other hand, with the improvement of education level and the development of the Internet, people's health awareness is also increasing. Various factors have contributed to the growing market for various vaccines and antibody drugs. Growth in the downstream market is driving the growth of the Stabilizers Used in Antibody Drugs and Vaccines market.

Region Overview:

USA had the highest growth rate of all regions.

Company Overview:

Roquette Pharma is one of the major players operating in the Stabilizers Used in Antibody Drugs and Vaccines market, holding a share of 16.19% in 2022.

Segmentation Overview:

Among different product types, Sugars segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Vaccines segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Stabilizers Used in Antibody Drugs and Vaccines market covered in Chapter 3:

Ashland, Inc.
Evonik Industries Ag
Wacker Chemie AG
Basf Se
P&G Chemicals
Roquette Pharma
Well Pharmaceutical
JRS Pharma
The Dow Chemical Company
Poly Pharmaceutical

In Chapter 4 and Chapter 14.2, on the basis of types, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2029 is primarily split into:

Amino Acids
Sugars
Proteins

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Stabilizers Used in Antibody Drugs and Vaccines market from 2018 to 2029 covers:

Antibody Drugs
Vaccines

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)